These changes in brain BDNF expression are paralleled by serum levels, so that it has been proposed as a biomarker for depression disease, positive or negative response of the individuals to the antidepressant treatment [153–156], and even a marker of suicidal depression [157]. This evidence concerns the gene BDNF and major depressive disorder.